NOT KNOWN FACTUAL STATEMENTS ABOUT WHAT ARE THE BEST NEUROPROTECTIVE DRUGS?

Dependant on the subgroup analysis, we uncovered that there was significant heterogeneity in terms of mortality, favorable outcomes, and the full procedure effective fee. Regarding mortality, The main reason for heterogeneity on the subgroup of edaravone dexborneol and EDV was primarily attributed to dissimilarities in drug dosage. Relating to favo